The IgA Nephropathy Foundation

????REMINDER???? DATE: Wednesday, November 20, 2024 TIME: 8:00 – 9:00 p.m. ET Are you interested in finding out about one of the latest emerging therapies for IgA nephropathy (IgAN)? Join us for a FREE WEBINAR brought to you by Travere Therapeutics to learn more. This webinar is intended for all, including individuals newly diagnosed with IgAN, individuals currently taking medication for IgAN, caregivers and care partners. https://lnkd.in/e3sXvnPt Please share with anyone else who might be interested. #IgANephropathy #IgANAware #IgANManagement #EmergingTherapy #StayInformed #LookingForward #PatientSupport

???????REMINDER Join us for a webinar for the I CAN Study on Immunoglobulin A Nephropathy on Thursday, November 7, from 7 to 8pm ET. All are welcome, including those taking medication for IgAN, their family, and care partners.? ? Register for the webinar at https://lnkd.in/gRfwm79s submit questions at [email protected], and find more information about the I CAN Study at ICANClinicalStudy.com.? ? ?

We are pleased to announce our participation as exhibitors and presenters at the @GlobalGenes Week in RARE event, scheduled for September 25-28. We invite you to join us alongside other advocates for rare diseases in a series of informative sessions focusing on best practices in advocacy, practical strategies for community engagement, and opportunities to forge valuable connections within the rare disease sector for future collaborations. ?? ???? For further details, please visit: https://lnkd.in/gveUGHXM #WeekinRARE #RARESummit #RAREHealthEquity #GGSummit #GlobalGenes

We’re grateful to everyone who has contributed to our ongoing mission to provide better treatments and support for people affected by IgA Nephropathy. As the only non-profit patient advocacy group dedicated entirely to IgAN, we’re proud of what we’ve accomplished. If you haven’t joined yet, now is the perfect time! Membership is free and provides access to clinical trials, mental health resources like Calm and Talkspace, monthly support meetings, and our new IgAN+ App. Together, we can continue making strides toward a brighter future. You are not alone. Join here: https://lnkd.in/g_PbdhEy #IgAN #PatientAdvocacy #NonProfit #HealthcareSupport #IgAnephropathy

? What an incredible success! ? We are so grateful to everyone who joined us for the inaugural #IgANHillDay! Thanks to your passion and commitment, we’ve made a meaningful impact in raising awareness about #IgANephropathy (IgAN) and advocating for the needs of our community. Together, we’re creating positive change and paving the way for better kidney health. A huge thank you to our dedicated advocates, patients, healthcare professionals, and all who supported this important cause. Your commitment is inspiring! ???? Want to get involved? You can help by contacting your representatives through our advocacy tool: https://lnkd.in/ejNbCcxj #IgANAwareness #KidneyHealth #AdvocacyInAction #MakingADifference #RareSighting #IganAdvocate

“As a parent of a son living with the disease for 20 years, I understand firsthand the fear and uncertainty that come with an IgAN diagnosis, and the devastating impact it can have on patients and their families,” said Bonnie Schneider, Director and Co-Founder, IgAN Foundation. “Today’s approval offers new hope for people living with IgA nephropathy as it represents a treatment innovation that provides us with a new way to fight this multifaceted disease.” Read the full press release https://lnkd.in/eaTs_z5G #iganephropathy #thefutureisbright

“As a parent of a son living with the disease for 20 years, I understand firsthand the fear and uncertainty that come with an IgAN diagnosis, and the devastating impact it can have on patients and their families,” said Bonnie Schneider, Director and Co-Founder, IgAN Foundation. “Today’s approval offers new hope for people living with IgA nephropathy as it represents a treatment innovation that provides us with a new way to fight this multifaceted disease.” Read the full press release https://lnkd.in/eaTs_z5G #iganephropathy #thefutureisbright

Clinical Trial Day is celebrated today on May 20th Today, we celebrate the incredible advancements in medical science and honor the pioneering work that has shaped modern healthcare. Let's take a moment to remember James Lind, who conducted one of the first controlled clinical trials in 1747. His groundbreaking scurvy trial on sailors proved that citrus fruits could prevent this debilitating disease, paving the way for evidence-based medicine. James Lind's innovative spirit reminds us of the importance of clinical trials in discovering new treatments and improving patient care. Here's to all the researchers, participants, and healthcare professionals who continue this vital work! #futurelooksbright Learn More about clinical trials for #iganephropathy ???? https://lnkd.in/es82MEiu #ClinicalTrialDay #ScurvyTrial #MedicalResearch #HealthcareHeroes #EvidenceBasedMedicine #HistoryOfMedicine ??????

The @IgANFoundation's 20-year #IgANjourney has yielded 2 treatments; SPARK; support groups; and membership including patient financial aid, the IgAN+ app, Calm, and Talkspace! #iganaware ???? Please share your story, a thank you or shout out, general kudos and sign our virtual KUDO board. https://bit.ly/24igankudo

A big thank you to everyone who has rallied behind @iganfoundation Your generosity, compassion, and commitment are the driving forces behind our quest for a cure. Let's continue standing together, making a difference, and bringing hope to those affected by this condition. We are humbled by our community of patients and caregivers in trusting us to help them navigate their #iganjourney We are the only 501c, patient advocacy group 100% dedicated to #iganephropathy YOU ARE NOT ALONE ???? Special thanks to our 2024 #iganaware sponsors Travere Therapeutics, Calliditas Therapeutics, Novartis, Alexion and Vera Therapeutics